Vous avez renseigné l'adresse d'un site internet Kleresca® qui n'est pas celui de votre pays d'origine. Veuillez noter que les informations disponibles sur ce site peuvent ne pas être applicables pour votre pays.
Preliminary study regarding the efficacy of FLE in the treatment of inflammatory skin conditions, rejuvenating the skin and as pre post with more invasive treatments. FLE effectively targets inflammation, induces angiogenesis and enhances fibroblastic collagen production.
Preliminary study to investigate some of the key mechanisms underlying the efficacy of fluorescent light energy (FLE). FLE effectively targets inflammation in acne and rosacea and offers support in these conditions by improving the skin’s overall texture and appearance of scars.
Study done with 98 patients suffering from moderate to sever acne. Patients had been non responders to isotretinoin treatments or they had absolute or relative contraindications against it. These cases
support the use of FLE as a new therapeutic approach to treat acne patients, reducing inflammatory lesions and associated redness.
A case study of a 49 year old patient suffering from acne eruption induced by erlotinib treatment. After trying different oral and systemic treatments, the use of Kleresca® Acne Treatment notably reduced the severity of her acne.
Patient with a 3 month history of papulopustular eruption as a result of granulomatous rosacea. A modest improvement was observed with topical systemic treatments. After Kleresca® , there was a significant improvement and no relapse after 6 months after treatment finalised.